Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Sanofi-Aventis S.A.
(OP:
SNYNF
)
108.00
+4.74 (+4.59%)
Streaming Delayed Price
Updated: 9:30 AM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
721
Open
108.00
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
103.26
Today's Range
108.00 - 108.00
52wk Range
86.12 - 110.16
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Standout Stocks to Buy for the Next Bull Market
July 18, 2024
These standout stocks to buy for a bull market offer promising potential for significant gains as market conditions continue to strengthen.
Via
InvestorPlace
The 16th Annual Global CSR & ESG Summit and Awards 2024: Celebrating Sustainable Leadership and Innovation, 25 April 2024
April 30, 2024
From
Pinnacle Group International
Via
ACN Newswire
Performance
YTD
+8.00%
+8.00%
1 Month
+4.44%
+4.44%
3 Month
+11.62%
+11.62%
6 Month
+14.77%
+14.77%
1 Year
+0.31%
+0.31%
More News
Read More
6 reasons to buy Teva Pharmaceuticals stock sooner than later
February 26, 2024
Via
MarketBeat
Topics
Lawsuit
Exposures
Financial
Legal
Teva Pharma is the way to play the re-rise of generic drugs
November 28, 2023
Via
MarketBeat
Pfizer and Sanofi shares fall, which one to scoop up?
November 07, 2023
Via
MarketBeat
Exposures
COVID-19
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
August 01, 2023
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Exscientia is the Sniper of the AI Drug Discovery Industry
July 27, 2023
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
DarioHealth is an AI-Powered Digital Therapeutics Play
June 13, 2023
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing
December 06, 2022
From
Singapore Economic Development Board (EDB)A*STAR
Via
ACN Newswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.